Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
autism
Marketing
GW plots path to new drug approvals as Epidiolex coasts
GW announced a phase 3 trial to treat spasticity in MS on the same day it posted 3Q results that beat predictions, led by epilepsy drug Epidiolex.
Beth Snyder Bulik
Nov 5, 2020 11:14am
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
Oct 5, 2018 11:24pm
Twitter is rife with antivaccine sentiment: study
Oct 10, 2017 5:28pm
Trump's FDA pick: Vaccine, autism claims 'debunked'
Mar 13, 2017 12:46pm
Journal pulls latest flawed study linking vaccines to autism
Dec 6, 2016 4:04pm